Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117795812 | 11779581 | 2 | F | 2006 | 20160822 | 20151125 | 20160829 | EXP | US-JAZZ-2015-US-020203 | JAZZ | 0.00 | F | Y | 0.00000 | 20160829 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117795812 | 11779581 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 1.5 G, BID | Y | 21196 | 1.5 | G | ORAL SOLUTION | ||||||
| 117795812 | 11779581 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | Y | 21196 | 2.25 | G | ORAL SOLUTION | ||||||
| 117795812 | 11779581 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | Y | 21196 | 3 | G | ORAL SOLUTION | ||||||
| 117795812 | 11779581 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | Y | 21196 | 3 | G | ORAL SOLUTION | ||||||
| 117795812 | 11779581 | 5 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | Y | 21196 | 3 | G | ORAL SOLUTION | ||||||
| 117795812 | 11779581 | 6 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.75 G, BID | Y | 21196 | 3.75 | G | ORAL SOLUTION | ||||||
| 117795812 | 11779581 | 7 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | Y | 21196 | 4.5 | G | ORAL SOLUTION | ||||||
| 117795812 | 11779581 | 8 | C | TOPAMAX | TOPIRAMATE | 1 | U | 0 | |||||||||||
| 117795812 | 11779581 | 9 | C | Enalapril | ENALAPRIL | 1 | U | 0 | |||||||||||
| 117795812 | 11779581 | 10 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | U | 0 | |||||||||||
| 117795812 | 11779581 | 11 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | U | 0 | ||||||||||
| 117795812 | 11779581 | 12 | C | NUVIGIL | ARMODAFINIL | 1 | UNK | U | 0 | ||||||||||
| 117795812 | 11779581 | 13 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117795812 | 11779581 | 1 | Narcolepsy |
| 117795812 | 11779581 | 2 | Cataplexy |
| 117795812 | 11779581 | 8 | Migraine |
| 117795812 | 11779581 | 9 | Product used for unknown indication |
| 117795812 | 11779581 | 10 | Product used for unknown indication |
| 117795812 | 11779581 | 11 | Product used for unknown indication |
| 117795812 | 11779581 | 12 | Product used for unknown indication |
| 117795812 | 11779581 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117795812 | 11779581 | OT |
| 117795812 | 11779581 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117795812 | 11779581 | Chest pain | |
| 117795812 | 11779581 | Hypertension | |
| 117795812 | 11779581 | Myocardial infarction | |
| 117795812 | 11779581 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117795812 | 11779581 | 1 | 200402 | 0 | ||
| 117795812 | 11779581 | 2 | 200406 | 0 | ||
| 117795812 | 11779581 | 3 | 200704 | 2007 | 0 | |
| 117795812 | 11779581 | 4 | 200807 | 2008 | 0 | |
| 117795812 | 11779581 | 5 | 201307 | 2013 | 0 | |
| 117795812 | 11779581 | 6 | 201310 | 2014 | 0 | |
| 117795812 | 11779581 | 7 | 201404 | 0 | ||
| 117795812 | 11779581 | 11 | 20160801 | 0 | ||
| 117795812 | 11779581 | 12 | 20160731 | 0 |